Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Paul J. Kostuchenko"'
Publikováno v:
Seminars in Surgical Oncology. 12:436-445
Melanoma has a somewhat unpredictable behavior, and spontaneous regressions do occasionally occur. Many have surmised that these are the result of immunologic attack by the host. Immunologic treatment has been more successful for melanoma than for mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b5286c8087c7cf8b026378271757a19
https://doi.org/10.1002/(sici)1098-2388(199611/12)12:6<436::aid-ssu9>3.0.co
https://doi.org/10.1002/(sici)1098-2388(199611/12)12:6<436::aid-ssu9>3.0.co
Autor:
Steven Grant, A J Turner, Marcus E. Carr, Harry D. Bear, Sheryl L. Carr, Paul J. Kostuchenko, Kenneth A Lipshy, Giselle G. Hamad, John D. Roberts, Andrew McFadden
Publikováno v:
Anti-Cancer Drugs. 7:299-306
Bryostatin 1 activates and subsequently down-regulates protein kinase C (PKC) in vitro and has potential use as an immunomodulator and as an anti-cancer agent. Despite extensive examination of its activities in vitro and anti-tumor effects in vivo, p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::713599cda2f89b22fd0476f6fb19b5f1
https://doi.org/10.1097/00001813-199605000-00010
https://doi.org/10.1097/00001813-199605000-00010
Autor:
Harry D. Bear, Kenneth A Lipshy, Sandra K. Barrett, Paul J. Kostuchenko, Diana Portocarero, Andrew McFadden, Martin D. Fleming
Publikováno v:
Journal of Immunotherapy. 18:147-155
Because the requirement for long-term cell culture can make adoptive cellular immunotherapy cumbersome, experiments were designed to determine whether smaller numbers of tumor-sensitized T cells activated briefly with bryostatin 1 and ionomycin (B/I)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::506c762f2e1fff8f276ea850fee649a5
https://doi.org/10.1097/00002371-199510000-00002
https://doi.org/10.1097/00002371-199510000-00002
Publikováno v:
Seminars in Surgical Oncology. 13:465-465
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::974ea2447581f8069886aa9f85f490e3
https://doi.org/10.1002/(sici)1098-2388(199711/12)13:6<465::aid-ssu12>3.0.co
https://doi.org/10.1002/(sici)1098-2388(199711/12)13:6<465::aid-ssu12>3.0.co
Autor:
Paul J. Kostuchenko, Andrew McFadden, S. Grant, A. Turner, S. Barrett, K. Burnes, Harry D. Bear
Publikováno v:
Journal of Immunotherapy. 16:241
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::036e2bc7380ac1c6baf4222a443b0acf
https://doi.org/10.1097/00002371-199410000-00035
https://doi.org/10.1097/00002371-199410000-00035